TSC2 and breast cancer: This effect was seen in bladder and breast cancer cell lines, lymphangioleiomyomatosis-derived cells, tuberous sclerosis complex 2 (TSC2)-deficient cell lines, as well as in TSC2-deficient mouse xenograft tumors.17,19–21